Update on Toxic Shock Syndrome
Toxic shock syndrome remains a serious, life-threatening complication of certain types of infections that can be fatal.
Nutrigenomics: How Genes and Nutrition Interact
Using nutrition to benefit health through the care and feeding of genes, though still in its infancy, is an exciting field of study seeing exponential growth.
Stopping Alzheimer’s with a Preventative Vaccine?
Despite the many vaccine candidates undergoing clinical trials, experts doubt an effective vaccine for Alzheimer’s disease is on the horizon.
The Future of Medicine with Artificial Intelligence
Healthcare professionals who do not embrace AI will eventually find themselves out of touch with the industry.
Agents That Block Plasma IgG Recycling: The Next Big Thing for IgG Antibody-Mediated Diseases?
New FcRn inhibitors may be a viable therapeutic option for certain patients currently treated withIG and plasma exchange.
Feeding China’s Growing Appetite for Human Albumin
To appreciate how the “Chinese economic miracle” has helped improve access in particular to advanced medical care, one need look no further than its utilization of a single product that is widely used in hospitals to treat severely ill intensive care unit and other patients. That product, now China’s highest dollar-value prescribed therapeutic, is human albumin.
Myths and Facts: Women and Cardiovascular Disease
Cardiovascular disease poses a significant risk for women, yet most women remain unaware mainly due to myths and misconceptions.
Following the Disease: Trends and Outbreaks Drive Subtle Changes to Vaccine Recommendations for Adolescents and Young Adults
Recent disease trends among adolescents and young adults have fueled vaccine schedule updates. Many have been outbreak-driven; others reflect vaccine improvements and innovations. All are critical to improve the health.
Vaccinations for Seniors: Addressing Compliance
Vaccine adherence rates for seniors are low, increasing health risks for this older population and beyond.
Human Albumin as Drug Therapy for Decompensated Cirrhosis: A New Lifesaving Role for an Old Player?
A growing body of evidence suggests known pharmacologic properties of human albumin may contribute to reducing the risk of a range of cirrhosis complications, including bacterial sepsis, irreversible renal injury and death.
